Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MRSOTSE:5619 40 Current Ratio is 7.86 as of Jun. 2026, which is at its 10-year median of 7.86. GuruFocus rates TSE:5619 with a GF Score™ of 40/100 and a GF Value™ of 円668.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 686 Healthcare Providers & Services companies, MRSO ranks better than 94.61% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. MRSO's current ratio for the quarter that ended in Jun. 2026 was 7.86.
MRSO has a current ratio of 7.86. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for MRSO's Current Ratio or its related term are showing as below:
TSE:5619'
s Current Ratio Range Over the Past 10 Years
Min: 2.53 Med: 7.86 Max: 11.51
Current: 7.86
During the past 5 years, MRSO's highest Current Ratio was 11.51. The lowest was 2.53. And the median was 7.86.
TSE:5619's Current Ratio is ranked better than 94.61% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.42
vs TSE:5619: 7.86
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
MRSO Current Ratio Related Terms
MRSO Current Ratio Historical Data
* Premium members only.
The historical data trend for MRSO's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:5619 vs VEEV, BTSG, HQY: Current Ratio Comparison
For the Health Information Services subindustry, MRSO's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MRSO Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MRSO's Current Ratio distribution charts can be found below:
* The bar in red indicates where MRSO's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MRSO (TSE:5619) has a Current Ratio of 7.86 as of Jun. 2026. This is near median its historical median of 7.86. Over the past decade, MRSO's Current Ratio has ranged from 2.53 to 11.51. According to the industry distribution chart, MRSO ranks #37 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 5.4%.
Is MRSO's Current Ratio too high?
MRSO's current Current Ratio of 7.86 is near median its 10-year median of 7.86. Over the past 10 years, this metric has ranged from a low of 2.53 to a high of 11.51. The Healthcare Providers & Services industry median Current Ratio is 1.42. MRSO's value of 7.86 is 453.5% above this industry median. Based on the distribution chart, MRSO ranks #37 out of 686 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MRSO has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MRSO's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MRSO ranks #37 out of 686 companies for Current Ratio. This places MRSO in the top 5% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.42. MRSO's value of 7.86 is 453.5% above this benchmark. Historically, MRSO's own Current Ratio has ranged from 2.53 to 11.51 over the past decade. While the company's 10-year median is 7.86 vs. the industry median of 1.42, MRSO has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.42, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MRSO's current Current Ratio of 7.86 is 453.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRSO's current Current Ratio is 7.86, which is near median its own 10-year median of 7.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRSO stock overvalued right now?
Based on GuruFocus' analysis, MRSO (TSE:5619) is currently considered Significantly Overvalued. The stock's GF Value™ is 円668.03, compared to a current price of 円905.00 — trading 35.5% above its estimated fair value. The current Current Ratio is 7.86, which is near median its 10-year median of 7.86 and 453.5% above the Healthcare Providers & Services industry median of 1.42. MRSO's overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For MRSO (TSE:5619), the current Current Ratio is 7.86 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRSO (TSE:5619) Overvalued in 2026?
Based on GuruFocus' analysis, MRSO stock appears to be overvalued.
The current stock price of 円905.00 is trading 35.5% above its estimated GF Value™ of 円668.03.
GuruFocus considers MRSO to be Significantly Overvalued.
Key valuation signals for TSE:5619:
Current Ratio: 7.86 (near median its 10-year median of 7.86)
GF Value™: 円668.03 vs. price of 円905.00 (35.5% above fair value)
Industry Position: 453.5% above the Healthcare Providers & Services median (#37 of 686)
No single metric tells the full story. See the TSE:5619 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRSO Inc operates a healthcare platform and provides vertical SaaS solutions for medical institutions, government entities, and corporations. The company offers a preventive medical platform that enables reservations for medical checkups and various cancer screenings. It also provides administrative DX services that support tasks carried out by local governments, including the acceptance of reservations for resident health checkups and vaccinations. These administrative DX services are used by local governments across regions with varying population sizes.
40GF Score
Get the complete analysis for TSE:5619
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:5619 has been successfully added to your 
